Management of delivery with FVIII/VWF concentrates in a pregnant woman with type 3 von Willebrand disease and alloantibodies

Thromb Haemost. 2012 Oct;108(4):796-8. doi: 10.1160/TH12-03-0136. Epub 2012 Jul 26.

Authors

Mónica Martín-Salces, Víctor Jiménez-Yuste, María Teresa Álvarez-Román, Isabel Rivas-Pollmar, Ana Rodríguez de la Rúa

PMID: 22836221
DOI: 10.1160/TH12-03-0136

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Antifibrinolytic Agents / administration & dosage
Blood Transfusion
Cesarean Section
Factor VIII / administration & dosage*
Female
Humans
Infant, Newborn
Isoantibodies / blood
Pregnancy
Pregnancy Complications, Hematologic / blood
Pregnancy Complications, Hematologic / immunology
Pregnancy Complications, Hematologic / therapy*
Tranexamic Acid / administration & dosage
Uterine Hemorrhage / etiology
Uterine Hemorrhage / therapy
von Willebrand Disease, Type 3 / blood
von Willebrand Disease, Type 3 / complications*
von Willebrand Disease, Type 3 / immunology
von Willebrand Disease, Type 3 / therapy*
von Willebrand Factor / administration & dosage*
von Willebrand Factor / immunology

Substances

Antifibrinolytic Agents
Isoantibodies
von Willebrand Factor
Tranexamic Acid
F8 protein, human
Factor VIII